𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients

✍ Scribed by Kristjan S Asgeirsson, Amit Agrawal, Claire Allen, Anthony Hitch…

Book ID
120699225
Publisher
BioMed Central
Year
2007
Tongue
English
Weight
470 KB
Volume
9
Category
Article
ISSN
1465-5411

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum epidermal growth factor receptor/H
Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer
✍ Christopher Souder; Kim Leitzel; Suhail M. Ali; Laurence Demers; Dean B. Evans; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR, HER‐1, and __erbB__1) is overexpressed in primary breast cancer and had been identified as a poor prognostic factor. ## METHODS. Pretreatment serum EGFR levels were quantified by using an enzyme‐linked immunoadsorbent assay in a

Expression of estrogen, progesterone and
Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer
✍ Ton van Agthoven; Mieke Timmermans; Lambert C. J. Dorssers; Sonja C. Henzen-Logm 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 473 KB 👁 2 views

The prognostic value of epidermal growth factor receptor (EGFR) expression and its biological role in estrogen receptorpositive (ER+) and ER-negative (ER-) primary breast cancer is controversial. In this study, distributions of ER, progesterone receptor and EGFR have been established using immunohis